Monocyte-Derived Dendritic Cells: An Updated View on an Old Concept
1Institut Necker Enfants Malades-INEM, CNRS, INSERM, Université Paris Cité, Paris, France.
Immunological Reviews
|November 17, 2025
Summary
Monocyte-derived dendritic cells (mo-DCs) are a distinct immune cell population. This review summarizes evidence for their existence, regulation, and therapeutic potential in immune responses.
Area of Science:
- Immunology
- Cell Biology
Background:
- Dendritic cells (DCs) are key antigen-presenting cells essential for T cell activation.
- Monocyte-derived dendritic cells (mo-DCs) have been observed in various conditions, but their distinct identity is debated due to similarities with other myeloid cells.
Purpose of the Study:
- To review the evidence supporting the existence of monocyte-derived dendritic cells (mo-DCs) in vivo.
- To discuss the molecular regulation of mo-DC differentiation.
- To explore the role of mo-DCs in immune responses and their therapeutic potential.
Main Methods:
- Literature review of studies on dendritic cell populations.
- Analysis of phenotypical and transcriptional data comparing DC subsets and monocyte-derived macrophages.
- Synthesis of findings on mo-DC differentiation and function.
Main Results:
- Evidence supports the existence of distinct mo-DCs in vivo.
- Molecular pathways regulating mo-DC differentiation are being elucidated.
- mo-DCs play significant roles in various immune responses.
Conclusions:
- Monocyte-derived dendritic cells (mo-DCs) represent a distinct population with critical immune functions.
- Understanding mo-DC differentiation offers potential therapeutic strategies for immune modulation.
